Evo Fund lowers stake in Oncolys BioPharma to 9.94%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-09-20 11:19 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 9.94%, previous report: 11.05%.